Concepedia
Statistics
Publications
22
Citations
1.5K
H-Index
15
Active since
1981
Affiliations
Harvard University(Current)
Brigham and Women's Hospital
T.J. Eberlein is an author at Harvard University specializing in oncology, medicine, and surgery.
Publications per year
1981–2016
Breast and ovarian cancer-specific cytotoxic T lymphocytes recognize the same HER2/neu-derived peptide.
George E. Peoples, Peter S. Goedegebuure, Robert W. Smith et al. · Proceedings of the National Academy of Sciences · 1995 · 440 citations
Life Sciences, Immunology, Oncology +17
Predictors of Invasive Breast Cancer in Patients With an Initial Diagnosis of Ductal Carcinoma In Situ: A Guide to Selective Use of Sentinel Lymph Node Biopsy in Management of Ductal Carcinoma In Situ
T.J. Eberlein · Yearbook of Surgery · 2006 · 237 citations
Medicine, Oncology, Surgery +17
Prognosis following salvage mastectomy for recurrence in the breast after conservative surgery and radiation therapy for early-stage breast cancer.
Anthony Abner, Abram Recht, T.J. Eberlein et al. · Journal of Clinical Oncology · 1993 · 201 citations
Adjuvant Chemotherapy Improves Survival after Resection of Hepatic Colorectal Metastases: Analysis of Data from Two Continents
T.J. Eberlein · Yearbook of Surgery · 2008 · 146 citations
Medicine, Oncology, Surgery +14
Adoptive immunotherapy of human cancer using low-dose recombinant interleukin 2 and lymphokine-activated killer cells.
Deric D. Schoof, B A Gramolini, David Davidson et al. · PubMed · 1988 · 87 citations
Pharmacy, Immunology, Oncology +17
1–5 of 22